Janus Henderson Group’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-851,494
| Closed | -$27.9M | – | 2724 |
|
|
2022
Q2 | $27.9M | Sell |
851,494
-309,286
| -27% | -$9.77M | 0.02% | 510 |
|
|
2022
Q1 | $30.5M | Buy |
1,160,780
+86,389
| +8% | +$2.11M | 0.01% | 640 |
|
|
2021
Q4 | $25.5M | Sell |
1,074,391
-68,372
| -6% | -$1.69M | 0.01% | 729 |
|
|
2021
Q3 | $28.7M | Buy |
1,142,763
+3,384
| +0.3% | +$86.2K | 0.01% | 703 |
|
|
2021
Q2 | $29.6M | Buy |
1,139,379
+34
| +0% | +$925 | 0.01% | 693 |
|
|
2021
Q1 | $29.2M | Sell |
1,139,345
-286
| -0% | -$7.33K | 0.01% | 688 |
|
|
2020
Q4 | $22.8M | Buy |
1,139,631
+376,129
| +49% | +$7.37M | 0.01% | 728 |
|
|
2020
Q3 | $13.1M | Buy |
+763,502
| New | +$14.4M | 0.01% | 781 |
|
|
2020
Q2 | – | Sell |
-1,182,206
| Closed | -$27.3M | – | 1404 |
|
|
2020
Q1 | $27.3M | Sell |
1,182,206
-604,714
| -34% | -$17.6M | 0.02% | 603 |
|
|
2019
Q4 | $59M | Sell |
1,786,920
-1,160,452
| -39% | -$37.2M | 0.03% | 534 |
|
|
2019
Q3 | $93.8M | Sell |
2,947,372
-305,779
| -9% | -$8.91M | 0.05% | 391 |
|
|
2019
Q2 | $83.6M | Sell |
3,253,151
-10,333
| -0.3% | -$263K | 0.05% | 429 |
|
|
2019
Q1 | $82.8M | Sell |
3,263,484
-5,702
| -0.2% | -$170K | 0.05% | 444 |
|
|
2018
Q4 | $111M | Buy |
3,269,186
+157,425
| +5% | +$5.12M | 0.07% | 318 |
|
|
2018
Q3 | $111M | Buy |
3,111,761
+396,772
| +15% | +$14M | 0.06% | 366 |
|
|
2018
Q2 | $93.7M | Sell |
2,714,989
-37,331
| -1% | -$1.31M | 0.05% | 397 |
|
|
2018
Q1 | $92.6M | Buy |
2,752,320
+631,060
| +30% | +$20M | 0.05% | 387 |
|
|
2017
Q4 | $81M | Buy |
2,121,260
+1,692,918
| +395% | +$67.6M | 0.05% | 413 |
|
|
2017
Q3 | $16.1M | Sell |
428,342
-24,763
| -5% | -$874K | 0.01% | 780 |
|
|
2017
Q2 | $16.9M | Sell |
453,105
-22,228
| -5% | -$803K | 0.01% | 779 |
|
|
2017
Q1 | $18.7M | Sell |
475,333
-21,861
| -4% | -$820K | 0.13% | 199 |
|
|
2016
Q4 | $17.3M | Buy |
497,194
+899
| +0.2% | +$35.3K | 0.13% | 211 |
|
|
2016
Q3 | $19.5M | Buy |
496,295
+124,769
| +34% | +$4.98M | 0.14% | 179 |
|
|
2016
Q2 | $14M | Buy |
371,526
+135,589
| +57% | +$4.54M | 0.12% | 221 |
|
|
2016
Q1 | $9.07M | Sell |
235,937
-7,088
| -3% | -$264K | 0.07% | 267 |
|
|
2015
Q4 | $11.7M | Buy |
243,025
+3,917
| +2% | +$181K | 0.09% | 239 |
|
|
2015
Q3 | $9.43M | Buy |
+239,108
| New | +$10.2M | 0.08% | 259 |
|
Other funds holding NTUS
Janus Henderson Group's NTUS Position: Q3 2022 in Review
Janus Henderson Group sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 851,494 shares — an estimated $27.9M sold.
Janus Henderson Group first reported a position in NTUS in Q3 2015 and held it in 27 quarters. The position peaked at $111M in Q4 2018. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Janus Henderson Group reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Janus Henderson Group sold 851,494 Natus Medical Inc shares in Q3 2022, an estimated $27.9M.
- Janus Henderson Group first reported a position in Natus Medical Inc in Q3 2015 and held it in 27 quarters.
- Janus Henderson Group's Natus Medical Inc position peaked at $111M in Q4 2018.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Janus Henderson Group's 13F filing for Q3 2022, filed 14 Nov 2022.